BioXcel Therapeutics (BTAIQ) EBIT (2017 - 2026)
BioXcel Therapeutics' EBIT was -$10.19 million in Q2 2026, compared with -$15.85 million a year earlier.
Powered by 
Analysis
BioXcel Therapeutics (BTAIQ) EBIT (2017 - 2026) Analysis & Trends
On a trailing twelve-month basis, BioXcel Therapeutics' EBIT was -$44.93 million through Jun 30, 2026; for FY2025, it was -$50.46 million.
- In earlier years, EBIT was -$67.25 million in FY2024, -$171.78 million in FY2023, -$159.65 million in FY2022 and -$106.94 million in FY2021.
- The Q2 2026 figure marks the highest quarterly EBIT since Q1 2025.
- Per Business Quant data, BTAIQ's EBIT in the three quarters before Q2 2026 was -$10.22 million (Q1 2026), -$10.28 million (Q4 2025) and -$14.23 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,146.94 Bn | 1,115.53 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 624.96 Bn | 543.49 Bn | 17.26 Bn | 7.14 Bn |
| 3 | AbbVie | 510.15 Bn | 483.27 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 366.13 Bn | 320.51 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 297.75 Bn | 261.74 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 261.93 Bn | 235.62 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 236.51 Bn | 191.91 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.27 Bn | 168.47 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 171.74 Bn | 118.39 Bn | 10.94 Bn | 4.27 Bn |
| 10 | BioXcel Therapeutics | 545,399.98 | -94.07 Mn | 160,000.00 | -10.19 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -10.19 Mn |
| Mar 31, 2026 | -10.22 Mn |
| Dec 31, 2025 | -10.28 Mn |
| Sep 30, 2025 | -14.23 Mn |
| Jun 30, 2025 | -15.85 Mn |
| Mar 31, 2025 | -10.10 Mn |
| Dec 31, 2024 | -10.49 Mn |
| Sep 30, 2024 | -15.29 Mn |
| Jun 30, 2024 | -17.30 Mn |
| Mar 31, 2024 | -24.16 Mn |
| Dec 31, 2023 | -19.88 Mn |
| Sep 30, 2023 | -48.30 Mn |
| Jun 30, 2023 | -52.41 Mn |
| Mar 31, 2023 | -51.20 Mn |
| Dec 31, 2022 | -52.89 Mn |
| Sep 30, 2022 | -38.99 Mn |
| Jun 30, 2022 | -36.29 Mn |
| Mar 31, 2022 | -31.48 Mn |
| Dec 31, 2021 | -26.13 Mn |
| Sep 30, 2021 | -26.81 Mn |
API Access
BioXcel Therapeutics EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=BTAIQ&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "BTAIQ", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=BTAIQ&period=max&api_key=YOUR_API_KEY");
const data = await res.json();